225 related articles for article (PubMed ID: 10967185)
21. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
22. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.
Senetta R; Miracco C; Lanzafame S; Chiusa L; Caltabiano R; Galia A; Stella G; Cassoni P
Neuro Oncol; 2011 Feb; 13(2):176-83. PubMed ID: 21059755
[TBL] [Abstract][Full Text] [Related]
25. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
Manasa LP; Uppin MS; Sundaram C
Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
[TBL] [Abstract][Full Text] [Related]
26. The clinical and prognostic relevance of grading in intracranial ependymomas.
Ernestus RI; Schröder R; Stützer H; Klug N
Br J Neurosurg; 1997 Oct; 11(5):421-8. PubMed ID: 9474274
[TBL] [Abstract][Full Text] [Related]
27. Nestin expression identifies ependymoma patients with poor outcome.
Milde T; Hielscher T; Witt H; Kool M; Mack SC; Deubzer HE; Oehme I; Lodrini M; Benner A; Taylor MD; von Deimling A; Kulozik AE; Pfister SM; Witt O; Korshunov A
Brain Pathol; 2012 Nov; 22(6):848-60. PubMed ID: 22568867
[TBL] [Abstract][Full Text] [Related]
28. Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD
Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.
Korshunov A; Sycheva R; Timirgaz V; Golanov A
J Neurooncol; 1999; 45(3):219-27. PubMed ID: 10845392
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
Ernestus RI; Schröder R; Stützer H; Klug N
Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
[TBL] [Abstract][Full Text] [Related]
32. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients.
Shaw EG; Evans RG; Scheithauer BW; Ilstrup DM; Earle JD
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1457-62. PubMed ID: 3624024
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclo-oxygenase-2 in ependymal tumors.
Roma AA; Prayson RA
Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
[TBL] [Abstract][Full Text] [Related]
36. Distribution of the extracellular matrix glycoproteins in ependymomas--an immunohistochemical study with follow-up analysis.
Zámecník J; Chánová M; Tichý M; Kodet R
Neoplasma; 2004; 51(3):214-22. PubMed ID: 15254676
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
39. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]